Pharmacological profile of novel psychoactive benzofurans

Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects

(2015) Yasmin Schmid et al.   BIOLOGICAL PSYCHIATRY

Monoamine transporter and receptor interaction profiles of novel psychoactive substances: Para-halogenated amphetamines and pyrovalerone cathinones

(2015) Anna Rickli et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

Synthesis and Structure–Activity Relationships of N-Benzyl Phenethylamines as 5-HT2A/2C Agonists

(2014) Martin Hansen et al.   ACS Chemical Neuroscience

Benzofuran analogues of amphetamine and methamphetamine: studies on the metabolism and toxicological analysis of 5-APB and 5-MAPB in urine and plasma using GC-MS and LC-(HR)-MSn techniques

(2014) Jessica Welter et al.   ANALYTICAL AND BIOANALYTICAL CHEMISTRY

Pharmacological profiles of aminoindanes, piperazines, and pipradrol derivatives

(2014) Linda D. Simmler et al.   BIOCHEMICAL PHARMACOLOGY

Trend analysis of anonymised pooled urine from portable street urinals in central London identifies variation in the use of novel psychoactive substances

(2014) J. R. H. Archer et al.   CLINICAL TOXICOLOGY

A 3-year review of new psychoactive substances in casework

(2014) Simon Elliott et al.   FORENSIC SCIENCE INTERNATIONAL

An analytical approach to the forensic identification of different classes of new psychoactive substances (NPSs) in seized materials

(2014) Sabina Strano Rossi et al.   RAPID COMMUNICATIONS IN MASS SPECTROMETRY

Hepatocellular toxicity of benzbromarone: Effects on mitochondrial function and structure

(2014) Andrea Felser et al.   TOXICOLOGY

The Concise Guide to PHARMACOLOGY 2013/14: Transporters

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors

(2013) Stephen P.H. Alexander et al.   BRITISH JOURNAL OF PHARMACOLOGY

Identification of (2-aminopropyl)benzofuran (APB) phenyl ring positional isomers in Internet purchased products

(2013) Andrzej Stanczuk et al.   Drug Testing and Analysis

New phenethylamines in Europe

(2013) L. A. King   Drug Testing and Analysis

Recreational use of 1-(2-naphthyl)-2-(1-pyrrolidinyl)-1-pentanone hydrochloride (NRG-1), 6-(2-aminopropyl) benzofuran (Benzofury/ 6-APB) and NRG-2 with review of available evidence-based literature

(2013) Jeshoor Jebadurai et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

Four Fatalities Involving 5-IT

(2013) L. N. Seetohul et al.   JOURNAL OF ANALYTICAL TOXICOLOGY

α1-Adrenergic Receptors Contribute to the Acute Effects of 3,4-Methylenedioxymethamphetamine in Humans

(2013) Cédric M. Hysek et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Monoamine transporter and receptor interaction profiles of a new series of designer cathinones

(2013) L.D. Simmler et al.   NEUROPHARMACOLOGY

The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands

(2013) Adam J. Pawson et al.   NUCLEIC ACIDS RESEARCH

The effects of benzofury (5-APB) on the dopamine transporter and 5-HT2-dependent vasoconstriction in the rat

(2013) Patrick Dawson et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function

(2013) Amy J. Eshleman et al.   PSYCHOPHARMACOLOGY

Pharmacological characterization of designer cathinonesin vitro

(2012) LD Simmler et al.   BRITISH JOURNAL OF PHARMACOLOGY

Neurochemical profiles of some novel psychoactive substances

(2012) Les Iversen et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Duloxetine Inhibits Effects of MDMA (“Ecstasy") In Vitro and in Humans in a Randomized Placebo-Controlled Laboratory Study

(2012) Cédric M. Hysek et al.   PLoS One

The Norepinephrine Transporter Inhibitor Reboxetine Reduces Stimulant Effects of MDMA (“Ecstasy”) in Humans

(2011) C M Hysek et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Clinical toxicology of newer recreational drugs

(2011) Simon L. Hill et al.   CLINICAL TOXICOLOGY

Genetic Deletion of Trace Amine 1 Receptors Reveals Their Role in Auto-Inhibiting the Actions of Ecstasy (MDMA)

(2011) B. Di Cara et al.   JOURNAL OF NEUROSCIENCE

The Designer Methcathinone Analogs, Mephedrone and Methylone, are Substrates for Monoamine Transporters in Brain Tissue

(2011) Michael H Baumann et al.   NEUROPSYCHOPHARMACOLOGY

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

(2011) F. G. Revel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives

(2010) JR Docherty et al.   BRITISH JOURNAL OF PHARMACOLOGY

Drug-induced fibrotic valvular heart disease

(2009) Sanjeev Bhattacharyya et al.   LANCET

A fatal poisoning involving Bromo-Dragonfly

(2008) Mette Findal Andreasen et al.   FORENSIC SCIENCE INTERNATIONAL